drugset / Trial / NCT00118404

Cognitive Therapy for Recurrent Depression

NCT00118404

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study determined the effectiveness of continuation phase cognitive therapy versus antidepressant medication in preventing relapse of depression in people with recurrent depression.

Timeline

Start
2000-03
Primary completion
2008-07
Completion
2008-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fluoxetine Small molecule 40 mg

Indications